PRIMARY OBJECTIVE: To summarize the literature on post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) and their co-morbidity, focusing on diagnosis, clinical symptoms and treatment issues relevant to the clinician. RESEARCH DESIGN: Review of the literature. METHODS AND PROCEDURES: Pubmed searches were performed using the terms post-traumatic stress disorder, traumatic brain injury, sleep, cognitive, depression, anxiety, treatment and combinations of these terms. Those articles relevant to the objective were included. MAIN OUTCOMES AND RESULTS: This study presents pathophysiological, neuroimaging and clinical data on co-morbid PTSD and TBI. It reviews associated conditions, emphasizing the impact of cognitive and sleep problems. It summarizes the emerging literature on treatment effectiveness for co-morbid PTSD and TBI, including psychotherapy, pharmacotherapy and cognitive rehabilitation. CONCLUSIONS: Both PTSD and TBI commonly occur in the general population, both share some pathophysiological characteristics and both are associated with cognitive impairment and sleep disruption. PTSD and TBI present with a number of overlapping symptoms, which can lead to over-diagnosis or misdiagnosis. Both conditions are associated with co-morbidities important in diagnosis and treatment planning. More research is needed to elucidate what treatments are effective in PTSD and TBI co-morbidity and on factors predictive of treatment success.
PRIMARY OBJECTIVE: To summarize the literature on post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) and their co-morbidity, focusing on diagnosis, clinical symptoms and treatment issues relevant to the clinician. RESEARCH DESIGN: Review of the literature. METHODS AND PROCEDURES: Pubmed searches were performed using the terms post-traumatic stress disorder, traumatic brain injury, sleep, cognitive, depression, anxiety, treatment and combinations of these terms. Those articles relevant to the objective were included. MAIN OUTCOMES AND RESULTS: This study presents pathophysiological, neuroimaging and clinical data on co-morbid PTSD and TBI. It reviews associated conditions, emphasizing the impact of cognitive and sleep problems. It summarizes the emerging literature on treatment effectiveness for co-morbid PTSD and TBI, including psychotherapy, pharmacotherapy and cognitive rehabilitation. CONCLUSIONS: Both PTSD and TBI commonly occur in the general population, both share some pathophysiological characteristics and both are associated with cognitive impairment and sleep disruption. PTSD and TBI present with a number of overlapping symptoms, which can lead to over-diagnosis or misdiagnosis. Both conditions are associated with co-morbidities important in diagnosis and treatment planning. More research is needed to elucidate what treatments are effective in PTSD and TBI co-morbidity and on factors predictive of treatment success.
Authors: Kimberly M Avallone; Erin R Smith; Sean Ma; Sean Gargan; Katherine E Porter; Caitlin C Authier; Brian Martis; Israel Liberzon; Sheila A M Rauch Journal: Mil Med Date: 2019-01-01 Impact factor: 1.437
Authors: Whitney A Ratliff; Ronald F Mervis; Bruce A Citron; Brian Schwartz; Vardit Rubovitch; Shaul Schreiber; Chaim G Pick Journal: Exp Neurol Date: 2019-01-31 Impact factor: 5.330
Authors: Philip A Cook; Thomas M Johnson; Suzanne G Martin; Philip R Gehrman; Seema Bhatnagar; James C Gee Journal: J Neurotrauma Date: 2018-03-01 Impact factor: 5.269
Authors: Allison R Kaup; Rosemary Toomey; Katherine J Bangen; Lisa Delano-Wood; Kristine Yaffe; Matthew S Panizzon; Michael J Lyons; Carol E Franz; William S Kremen Journal: J Neurotrauma Date: 2018-09-04 Impact factor: 5.269
Authors: Kristen Dams-OʼConnor; Joshua B Cantor; Margaret Brown; Marcel P Dijkers; Lisa A Spielman; Wayne A Gordon Journal: J Head Trauma Rehabil Date: 2014 Nov-Dec Impact factor: 2.710
Authors: Murray B Stein; Ronald C Kessler; Steven G Heeringa; Sonia Jain; Laura Campbell-Sills; Lisa J Colpe; Carol S Fullerton; Matthew K Nock; Nancy A Sampson; Michael Schoenbaum; Xiaoying Sun; Michael L Thomas; Robert J Ursano Journal: Am J Psychiatry Date: 2015-09-04 Impact factor: 18.112
Authors: Thomas W McAllister; Ross Zafonte; Sonia Jain; Laura A Flashman; Mark S George; Gerald A Grant; Feng He; James B Lohr; Norberto Andaluz; Lanier Summerall; Martin P Paulus; Rema Raman; Murray B Stein Journal: Neuropsychopharmacology Date: 2015-09-11 Impact factor: 7.853
Authors: Brett S Schneider; David B Arciniegas; Carla Harenski; Gerard Janez Brett Clarke; Kent A Kiehl; Michael Koenigs Journal: Brain Inj Date: 2022-01-22 Impact factor: 2.311